Secondary Graft Loss After Third-party "Off-The-Shelf" Antigen-Specific T cell Infusion
Creators
- Keller, Michael1
-
Schattgen, Stefan2
-
Chandrakasan, Shanmuganathan3
- Allen, E. Kaitlynn2
- Jensen-Wachspress, Mariah1
- Lazarski, Christopher1
- Qayed, Muna3
- Lang, Haili1
- Hanley, Patrick1
- Tanna, Jay1
-
Pai, Sung-Yun4
- Parikh, Suhag3
- Berger, Seth1
-
Gottschalk, Stephen2
-
Pulsipher, Michael5
-
Thomas, Paul2
- Bollard, Catherine1
- 1. Children's National Hospital
- 2. St. Jude Children's Research Hospital
- 3. Children's Hospital Atlanta
- 4. National Cancer Institute
- 5. University of Utah Health Huntsman Cancer Institute
Description
Here, we describe a severe adverse event of virus-specific T cell (VST therapy) in an infant with severe combined immunodeficiency who received VSTs for treatment of CMV viremia post-transplant and developed secondary graft rejection at 1-month post-VST infusion associated with the expansion of VST donor-derived T cells. Deposited here are the bulk repertoire and single-cell gene expression and TCR data from the study.
bulk_rep.zip contains tables of alpha/beta TCR sequences for post-infusion, VST donor, and VST product samples, and samples stimulated with neoepitope peptides.
VST_agg_wTCR_SS.rds is an R Data Serialization file containing a Seurat object of the processed 10X single-cell gene expression and TCR profiling for the post-infusion, VST donor, and VST product samples. TCR information is stored in the meta.data slot.
Files
bulk_tcr.zip
Files
(113.5 MB)
Name | Size | Download all |
---|---|---|
md5:a80e1467975902da6784dcef6400b29c
|
3.7 MB | Preview Download |
md5:e22ed4740496b26f56ccd9618ebdb4c2
|
109.7 MB | Download |